Clinical Trial Update: Treatment of ITP With Rituximab and / or Accutane [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating rituximab, with or without isotretinoin (Accutane), for immune thrombocytopenia, sponsored by Peking University People's Hos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Thrombocytopenia

Drugs mentioned

• Accutane (isotretinoin)
• Rituximab (rituximab)

Snippet

Sponsor: Peking University People's Hospital | Conditions: Immune Thrombocytopenia | Phase 2 | Status: UNKNOWN